Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

被引:234
作者
Yang, JW [1 ]
Shultz, RW [1 ]
Mars, WM [1 ]
Wegner, RE [1 ]
Li, YJ [1 ]
Dai, CS [1 ]
Nejak, K [1 ]
Liu, YH [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Div Cellular & Mol Pathol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1172/JC1200216219
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue-type plasminogen activator (tPA) is one of the major components in the matrix proteolytic network whose role in the pathogenesis of renal interstitial fibrosis remains largely unknown. Here, we demonstrate that ablation of tPA attenuated renal interstitial fibrotic lesions in obstructive nephropathy. Mice lacking tPA developed less morphological injury and displayed a reduced deposition of interstitial collagen III and fibronectin as well as total tissue collagen in the kidneys after sustained ureteral obstruction, when compared with their wild-type counterparts. Deficiency of tPA selectively blocked tubular epithehal-to-myofibroblast transition (EMT), but did not affect myofibroblastic activation from interstitial fibroblasts. A marked decrease in matrix metalloproteinase-9 (MMP-9) induction was found in the obstructed kidneys of tPA(-/-) mice, which led to a dramatic preservation of the structural and functional integrity of tubular basement membrane (TBM). In vitro, tPA induced MMP-9 gene expression and protein secretion in renal interstitial fibroblasts. Thus, increased tPA is detrimental in renal interstitial fibrogenesis through a cascade of events that lead to MMP-9 induction, TBM destruction, and promotion of EMT. Our findings establish a crucial and definite importance of EMT in the pathogenesis of renal interstitial fibrosis at the whole-animal level.
引用
收藏
页码:1525 / 1538
页数:14
相关论文
共 62 条
  • [31] MARS WM, 1993, AM J PATHOL, V143, P949
  • [32] Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
    Matsumoto, K
    Nakamura, T
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (06) : 2023 - 2038
  • [33] PROTEOLYTIC ACTIVATION OF A SINGLE-CHAIN PRECURSOR OF HEPATOCYTE GROWTH-FACTOR BY EXTRACELLULAR SERINE-PROTEASE
    MIZUNO, K
    TAKEHARA, T
    NAKAMURA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (03) : 1631 - 1638
  • [34] Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma
    Mori, T
    Wang, XY
    Kline, AE
    Siao, CJ
    Dixon, CE
    Tsirka, SE
    Lo, EH
    [J]. NEUROREPORT, 2001, 12 (18) : 4117 - 4120
  • [35] MOLECULAR-CLONING AND EXPRESSION OF HUMAN HEPATOCYTE GROWTH-FACTOR
    NAKAMURA, T
    NISHIZAWA, T
    HAGIYA, M
    SEKI, T
    SHIMONISHI, M
    SUGIMURA, A
    TASHIRO, K
    SHIMIZU, S
    [J]. NATURE, 1989, 342 (6248) : 440 - 443
  • [36] Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats
    Ng, YY
    Huang, TP
    Yang, WC
    Chen, ZP
    Yang, AH
    Mu, W
    Nikolic-Paterson, DJ
    Atkins, RC
    Lan, HY
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (03) : 864 - 876
  • [37] PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
    Oda, T
    Jung, YO
    Kim, HS
    Cai, XH
    López-Guisa, JM
    Ikeda, Y
    Eddy, AA
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (02) : 587 - 596
  • [38] Early role of Fsp1 in epithelial-mesenchymal transformation
    Okada, H
    Danoff, TM
    Kalluri, R
    Neilson, EG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (04) : F563 - F574
  • [39] Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo
    Okada, H
    Inoue, T
    Suzuki, H
    Strutz, F
    Neilson, EG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 44 - 46
  • [40] Discovery of potent, achiral matrix metalloproteinase inhibitors
    Pikul, S
    Dunham, KLM
    Almstead, NG
    De, B
    Natchus, MG
    Anastasio, MV
    McPhail, SJ
    Snider, CE
    Taiwo, YO
    Rydel, T
    Dunaway, CM
    Gu, F
    Mieling, GE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (19) : 3568 - 3571